PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcmedicineBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Medicine
 
BMC Med. 2012; 10: 7.
Published online Jan 20, 2012. doi:  10.1186/1741-7015-10-7
PMCID: PMC3275505
The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department
Christian H Nickel,corresponding author1 Roland Bingisser,1 and Nils G Morgenthaler2
1Emergency Department, University Hospital, Basel, Switzerland
2Institut für Experimentelle Endokrinologie und Endokrinologisches Forschungszentrum, EnForCé, Charité, Campus Virchow, Berlin, Germany
corresponding authorCorresponding author.
Christian H Nickel: nickelc/at/uhbs.ch; Roland Bingisser: bingisserr/at/uhbs.ch; Nils G Morgenthaler: Nils.Morgenthaler/at/charite.de
Received September 2, 2011; Accepted January 20, 2012.
Abstract
The hypothalamic-pituitary-adrenal axis is activated in response to stress. One of the activated hypothalamic hormones is arginine vasopressin, a hormone involved in hemodynamics and osmoregulation. Copeptin, the C-terminal part of the arginine vasopressin precursor peptide, is a sensitive and stable surrogate marker for arginine vasopressin release. Measurement of copeptin levels has been shown to be useful in a variety of clinical scenarios, particularly as a prognostic marker in patients with acute diseases such as lower respiratory tract infection, heart disease and stroke. The measurement of copeptin levels may provide crucial information for risk stratification in a variety of clinical situations. As such, the emergency department appears to be the ideal setting for its potential use. This review summarizes the recent progress towards determining the prognostic and diagnostic value of copeptin in the emergency department.
Articles from BMC Medicine are provided here courtesy of
BioMed Central